Published in PLoS One on February 04, 2013
Intracellular bacteria interfere with dendritic cell functions: role of the type I interferon pathway. PLoS One (2014) 0.98
Brucella discriminates between mouse dendritic cell subsets upon in vitro infection. Virulence (2015) 0.87
Lipopolysaccharides attenuates growth of HS cells through the JNK pathway. Cytotechnology (2016) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
How regulatory T cells work. Nat Rev Immunol (2008) 11.66
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
TLR signaling. Cell Death Differ (2006) 9.24
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 6.04
Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol (2003) 5.54
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods (2006) 5.25
A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med (2000) 5.11
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol (2001) 5.11
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol (2002) 4.64
Control of regulatory T cell lineage commitment and maintenance. Immunity (2009) 4.63
Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol (2007) 4.56
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med (2010) 4.17
Characterization of human blood dendritic cell subsets. Blood (2002) 3.97
Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol (2002) 3.79
Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol (1999) 2.85
Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med (2002) 2.37
Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol (2010) 2.29
Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood (2010) 2.09
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood (2007) 1.67
Antigen-specific regulatory T cells--their induction and role in infection. Semin Immunol (2004) 1.63
Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe (2008) 1.59
Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res (2005) 1.53
ER and aging-Protein folding and the ER stress response. Ageing Res Rev (2009) 1.50
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect (2003) 1.30
Aggregates are the biologically active units of endotoxin. J Biol Chem (2004) 1.23
Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides. Cell Microbiol (2006) 1.16
Immunity and the regulation of protein synthesis: surprising connections. Curr Opin Immunol (2009) 1.00
The generalized endotoxic principle. Eur J Immunol (2003) 0.86
Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med (2003) 3.23
Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J (2003) 2.87
Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nat Immunol (2005) 2.51
Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog (2008) 2.38
Brucella evolution and taxonomy. Vet Microbiol (2002) 2.29
Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol (2005) 2.05
The intracellular fate of Salmonella depends on the recruitment of kinesin. Science (2005) 1.92
Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One (2007) 1.82
Mimivirus giant particles incorporate a large fraction of anonymous and unique gene products. J Virol (2006) 1.76
Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev (2012) 1.75
Brucella coopts the small GTPase Sar1 for intracellular replication. Proc Natl Acad Sci U S A (2005) 1.70
Pathogenic brucellae replicate in human trophoblasts. J Infect Dis (2013) 1.66
The Salmonella effector protein PipB2 is a linker for kinesin-1. Proc Natl Acad Sci U S A (2006) 1.54
Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol (2010) 1.53
Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology (2011) 1.51
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med (2012) 1.50
Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr Opin Microbiol (2004) 1.47
Nanobacteria are mineralo fetuin complexes. PLoS Pathog (2008) 1.42
An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev (2011) 1.39
The translocated Salmonella effector proteins SseF and SseG interact and are required to establish an intracellular replication niche. Infect Immun (2006) 1.39
Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing. J Immunol (2002) 1.38
Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS One (2008) 1.37
Salmonella typhimurium SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its biological function. J Biol Chem (2003) 1.36
A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity (2009) 1.33
Pathogenic bacteria and dead cells are internalized by a unique subset of Peyer's patch dendritic cells that express lysozyme. Gastroenterology (2009) 1.31
Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol. Mol Microbiol (2005) 1.29
The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis (2011) 1.27
In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system. Cell Microbiol (2011) 1.26
Identification of a Brucella spp. secreted effector specifically interacting with human small GTPase Rab2. Cell Microbiol (2011) 1.22
The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides. J Bacteriol (2005) 1.17
The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog (2012) 1.17
Salmonella detoxifying enzymes are sufficient to cope with the host oxidative burst. Mol Microbiol (2011) 1.17
Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides. Cell Microbiol (2006) 1.16
Synthesis of phosphatidylcholine, a typical eukaryotic phospholipid, is necessary for full virulence of the intracellular bacterial parasite Brucella abortus. Cell Microbiol (2006) 1.16
Identification of two putative rickettsial adhesins by proteomic analysis. Res Microbiol (2006) 1.16
The glyceraldehyde-3-phosphate dehydrogenase and the small GTPase Rab 2 are crucial for Brucella replication. PLoS Pathog (2009) 1.16
BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions. Front Cell Infect Microbiol (2013) 1.16
The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood (2012) 1.15
Activation of Rho and Rab GTPases dissociates Brucella abortus internalization from intracellular trafficking. Cell Microbiol (2002) 1.14
What have we learned from brucellosis in the mouse model? Vet Res (2012) 1.13
DNA polymorphism analysis of Brucella lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between smooth and rough Brucella species and novel species-specific markers. BMC Microbiol (2009) 1.11
Contrasting roles of macrophages and dendritic cells in controlling initial pulmonary Brucella infection. Eur J Immunol (2010) 1.11
Targeting human dendritic cell subsets for improved vaccines. Semin Immunol (2011) 1.09
Extensive cell envelope modulation is associated with virulence in Brucella abortus. J Proteome Res (2007) 1.09
Molecular motors hijacking by intracellular pathogens. Cell Microbiol (2006) 1.08
Helicobacter pylori impairs murine dendritic cell responses to infection. PLoS One (2010) 1.08
The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect Immun (2010) 1.08
Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J Exp Med (2012) 1.08
Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Vaccine (2006) 1.06
Improved methods for producing outer membrane vesicles in Gram-negative bacteria. Res Microbiol (2004) 1.05
Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. Infect Immun (2002) 1.05
Specificity dependence between serological tests for diagnosing bovine brucellosis in Brucella-free farms showing false positive serological reactions due to Yersinia enterocolitica O:9. Can Vet J (2005) 1.01
The differential interaction of Brucella and ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens. PLoS One (2009) 1.01
The virulence protein SopD2 regulates membrane dynamics of Salmonella-containing vacuoles. PLoS Pathog (2010) 1.00
SKIP, the host target of the Salmonella virulence factor SifA, promotes kinesin-1-dependent vacuolar membrane exchanges. Traffic (2010) 1.00
Transcriptome analysis of the Brucella abortus BvrR/BvrS two-component regulatory system. PLoS One (2010) 1.00
Intracellular trafficking of Parachlamydia acanthamoebae. Cell Microbiol (2005) 0.98
Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo. J Immunol (2012) 0.97
Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J Infect Dis (2004) 0.97
Macropinocytosis of polyplexes and recycling of plasmid via the clathrin-dependent pathway impair the transfection efficiency of human hepatocarcinoma cells. Mol Ther (2004) 0.97
Proteome analysis of Rickettsia conorii by two-dimensional gel electrophoresis coupled with mass spectrometry. FEMS Microbiol Lett (2005) 0.96
The cytoplasmic tail of invariant chain regulates endosome fusion and morphology. Mol Biol Cell (2002) 0.95
Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother (2010) 0.94
Proteome analysis of Rickettsia felis highlights the expression profile of intracellular bacteria. Proteomics (2007) 0.94
Brucella T4SS: the VIP pass inside host cells. Curr Opin Microbiol (2013) 0.93
Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev Mol Med (2007) 0.93
Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection. Cancer Immunol Res (2014) 0.93
Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome. BMC Genomics (2010) 0.92
Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog (2012) 0.92
Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides. BMC Microbiol (2008) 0.92
Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B. Biophys J (2007) 0.91
Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts. Cell Microbiol (2006) 0.90
The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovar. PLoS One (2013) 0.90
BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence. Infect Immun (2007) 0.90
Placental macrophages are impaired in chorioamnionitis, an infectious pathology of the placenta. J Immunol (2013) 0.89
Brucellosis seroprevalence in livestock in Uganda from 1998 to 2008: a retrospective study. Trop Anim Health Prod (2010) 0.88
Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway. MBio (2012) 0.88
Lipopolysaccharide as a target for brucellosis vaccine design. Microb Pathog (2012) 0.88
Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice. Vaccine (2010) 0.88
Genomic island 2 is an unstable genetic element contributing to Brucella lipopolysaccharide spontaneous smooth-to-rough dissociation. J Bacteriol (2010) 0.87
Interaction between the SifA virulence factor and its host target SKIP is essential for Salmonella pathogenesis. J Biol Chem (2009) 0.87
Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2. Antimicrob Agents Chemother (2005) 0.87
Spontaneous excision of the O-polysaccharide wbkA glycosyltranferase gene is a cause of dissociation of smooth to rough Brucella colonies. J Bacteriol (2012) 0.86
Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus. PLoS Pathog (2013) 0.86
Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice. Vet Res (2014) 0.86
The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation. Blood (2008) 0.85
Brucella evasion of adaptive immunity. Future Microbiol (2013) 0.84
Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. Toxicon (2005) 0.84
Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen-associated molecular pattern. PLoS One (2011) 0.84
CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates. Eur J Immunol (2012) 0.83
Is Brucella an enteric pathogen? Nat Rev Microbiol (2009) 0.83
Orientia tsutsugamushi, the causative agent of scrub typhus, induces an inflammatory program in human macrophages. Microb Pathog (2012) 0.83